These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein. Teng Y; Zhao J; Ding L; Ding Y; Zhou P Molecules; 2019 Aug; 24(16):. PubMed ID: 31416122 [TBL] [Abstract][Full Text] [Related]
3. Cu Wang H; Mörman C; Sternke-Hoffmann R; Huang CY; Prota A; Ma P; Luo J J Inorg Biochem; 2022 Nov; 236():111945. PubMed ID: 35952593 [TBL] [Abstract][Full Text] [Related]
4. How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology. Kumar ST; Jagannath S; Francois C; Vanderstichele H; Stoops E; Lashuel HA Neurobiol Dis; 2020 Dec; 146():105086. PubMed ID: 32971232 [TBL] [Abstract][Full Text] [Related]
5. Alpha Synuclein only Forms Fibrils In Vitro when Larger than its Critical Size of 70 Monomers. Sanchez SE; Whiten DR; Meisl G; Ruggeri FS; Hidari E; Klenerman D Chembiochem; 2021 Oct; 22(19):2867-2871. PubMed ID: 34383993 [TBL] [Abstract][Full Text] [Related]
6. Phosphatidylcholine and Phosphatidylserine Uniquely Modify the Secondary Structure of α-Synuclein Oligomers Formed in Their Presence at the Early Stages of Protein Aggregation. Dou T; Kurouski D ACS Chem Neurosci; 2022 Aug; 13(16):2380-2385. PubMed ID: 35904551 [TBL] [Abstract][Full Text] [Related]
7. Scutellarin inhibits the uninduced and metal-induced aggregation of α-Synuclein and disaggregates preformed fibrils: implications for Parkinson's disease. Zaidi FK; Deep S Biochem J; 2020 Feb; 477(3):645-670. PubMed ID: 31939603 [TBL] [Abstract][Full Text] [Related]
8. Copper and iron ions accelerate the prion-like propagation of α-synuclein: A vicious cycle in Parkinson's disease. Li Y; Yang C; Wang S; Yang D; Zhang Y; Xu L; Ma L; Zheng J; Petersen RB; Zheng L; Chen H; Huang K Int J Biol Macromol; 2020 Nov; 163():562-573. PubMed ID: 32629061 [TBL] [Abstract][Full Text] [Related]
9. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice. Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxic Oligomers and Fibrils Trapped in a Gel-like State of α-Synuclein Assemblies. Kumar R; Das S; Mohite GM; Rout SK; Halder S; Jha NN; Ray S; Mehra S; Agarwal V; Maji SK Angew Chem Int Ed Engl; 2018 May; 57(19):5262-5266. PubMed ID: 29524323 [TBL] [Abstract][Full Text] [Related]
11. Calcium(II) selectively induces alpha-synuclein annular oligomers via interaction with the C-terminal domain. Lowe R; Pountney DL; Jensen PH; Gai WP; Voelcker NH Protein Sci; 2004 Dec; 13(12):3245-52. PubMed ID: 15537754 [TBL] [Abstract][Full Text] [Related]
12. A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α-synuclein research. Kumar ST; Donzelli S; Chiki A; Syed MMK; Lashuel HA J Neurochem; 2020 Apr; 153(1):103-119. PubMed ID: 31925956 [TBL] [Abstract][Full Text] [Related]
13. Unravelling the Structural Organization of Individual α-Synuclein Oligomers Grown in the Presence of Phospholipids. Dou T; Zhou L; Kurouski D J Phys Chem Lett; 2021 May; 12(18):4407-4414. PubMed ID: 33945282 [TBL] [Abstract][Full Text] [Related]
14. The Role of α-Synuclein Oligomers in Parkinson's Disease. Du XY; Xie XX; Liu RT Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212758 [TBL] [Abstract][Full Text] [Related]
15. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations. Sahay S; Ghosh D; Singh PK; Maji SK Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727 [TBL] [Abstract][Full Text] [Related]
16. The effect of fluorescent labeling on α-synuclein fibril morphology. Mučibabić M; Apetri MM; Canters GW; Aartsma TJ Biochim Biophys Acta; 2016 Oct; 1864(10):1419-27. PubMed ID: 27475048 [TBL] [Abstract][Full Text] [Related]
17. The involvement of dityrosine crosslinking in α-synuclein assembly and deposition in Lewy Bodies in Parkinson's disease. Al-Hilaly YK; Biasetti L; Blakeman BJ; Pollack SJ; Zibaee S; Abdul-Sada A; Thorpe JR; Xue WF; Serpell LC Sci Rep; 2016 Dec; 6():39171. PubMed ID: 27982082 [TBL] [Abstract][Full Text] [Related]
18. Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein. Sengupta U; Puangmalai N; Bhatt N; Garcia S; Zhao Y; Kayed R Mol Neurobiol; 2020 Jun; 57(6):2741-2765. PubMed ID: 32350746 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disorders. Lu Y; Prudent M; Fauvet B; Lashuel HA; Girault HH ACS Chem Neurosci; 2011 Nov; 2(11):667-75. PubMed ID: 22860160 [TBL] [Abstract][Full Text] [Related]
20. Identification and nanomechanical characterization of the fundamental single-strand protofilaments of amyloid α-synuclein fibrils. Ruggeri FS; Benedetti F; Knowles TPJ; Lashuel HA; Sekatskii S; Dietler G Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7230-7235. PubMed ID: 29941606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]